MARC details
| 000 -LÍDER |
|---|
| fixed length control field |
06225nam a22004815i 4500 |
| 001 - NÚMERO DE CONTROL |
|---|
| control field |
u372622 |
| 003 - IDENTIFICADOR DEL NÚMERO DE CONTROL |
|---|
| control field |
SIRSI |
| 005 - FECHA Y HORA DE LA ULTIMA TRANSACCIÓN |
|---|
| control field |
20160812084107.0 |
| 007 - CAMPO FIJO DE DESCRIPCIÓN FIJA--INFORMACIÓN GENERAL |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - ELEMENTOS DE LONGITUD FIJA -- INFORMACIÓN GENERAL |
|---|
| fixed length control field |
101217s2011 xxu| s |||| 0|eng d |
| 020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS |
|---|
| International Standard Book Number |
9781607618577 |
| -- |
978-1-60761-857-7 |
| 040 ## - FUENTE DE CATALOGACIÓN |
|---|
| Transcribing agency |
MX-MeUAM |
| 050 #4 - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO |
|---|
| Classification number |
QH573-671 |
| 082 04 - NÚMERO DE CLASIFICACIÓN DECIMAL DEWEY |
|---|
| Classification number |
571.9453 |
| Edition number |
23 |
| 100 1# - ASIENTO PRINCIPAL--NOMBRE PERSONAL |
|---|
| Personal name |
Miyata, Toshio. |
| Relator term |
editor. |
| 245 10 - MENCIÓN DE TITULO |
|---|
| Title |
Studies on Renal Disorders |
| Medium |
[recurso electrónico] / |
| Statement of responsibility, etc. |
edited by Toshio Miyata, Kai-Uwe Eckardt, Masaomi Nangaku. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Totowa, NJ : |
| Name of producer, publisher, distributor, manufacturer |
Humana Press, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2011. |
| 300 ## - DESCRIPCIÓN FÍSICA |
|---|
| Extent |
XVIII, 800p. 101 illus., 31 illus. in color. |
| Other physical details |
online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 490 1# - MENCIÓN DE SERIE |
|---|
| Series statement |
Oxidative Stress in Applied Basic Research and Clinical Practice |
| 505 0# - NOTA DE CONTENIDO |
|---|
| Formatted contents note |
Preface -- Chapter 1. Oxidative stress injury in glomerular mesangium -- Chapter 2. Transition Metals and other Forms of Oxidative Protein Damage in -- Renal Disease -- Chapter 3. Cyclo-oxygenase in the kidney and oxidative stress -- Chapter 4. Renin angiotensin system in the kidney and oxidative stress -Local Renin-Angiotensin-Aldosterone-System and NAD(P)H oxidase-dependent oxidative stress in the kidney- -- Chapter 5. Thiamine in diabetic renal disease – dietary insufficiency, renal -- washout, anti-stress gene response, therapeutic supplements, risk predictor and link to genetic susceptibility -- Chapter 6. Novel members of the globin family and their function against oxidative stress -- Clinical Aspects of Oxidative Stress in the Kidney -- Chapter 7. Hypertension -- Chapter 8. Uric acid and oxidative stress -- Chapter 9. Reactive oxygen and nitrogen species, oxidative and nitrosative -- stress and their role in the pathogenesis of acute kidney injury -- Chapter 10. Oxidative stress in the kidney: proximal tubule disorders -- Chapter 11. Iron metabolism and oxidative stress -- Chapter 12. Hypoxia, oxidative stress and the pathophysiology of contrast-media-induced nephropathy -- Chapter 13. Cardiovascular complications in renal failure: implications of advanced glycation end-products and their receptor, RAGE -- Chapter 14. Infection and the kidney -- Chapter 15. Oxidative/carbonyl stress in the renal circulation and cardiovascular renal injury -- -- Current Therapy Targeting Oxidative Stress -- Chapter 16. Renin angiotensin system -- Chapter 17. Oxidative stress in kidney injury-peroxisome proliferator-activated receptor-? agonists are in control -- Chapter 18. Statin -- Chapter 19. N-acetylcysteine in kidney disease -- Chapter 20. Advanced glycation end products (AGEs) inhibitor -- Section 2. ‘Hypoxia’ -- Hypoxia Biology -- Chapter 21. Involvement of hypoxia-inducible factor 1 in physiological and pathological responses to continuous and intermittent hypoxia: Role of reactive oxygen species -- Chapter 22. Regulation of oxygen homeostasis by PHDs -- Chapter 23. Oxygen-dependent regulation of erythropoiesis -- Chapter 24. Intricate link between hypoxia and oxidative stress in chronic kidney disease -- Chapter 25. RNA interference and the regulation of renal gene expression in -- hypoxia -- Hypoxia Pathology in Renal Disorders -- Chapter 26.Cardio-renal connection: The role of hypoxia and oxidative stress -- Chapter 27. HIF in acute kidney injury – from pathophysiology to a novel approach of organ protection -- Chapter 28. Hypoxia in chronic kidney disease: the final common pathway to end stage renal disease -- Chapter 29. Oxidative stress and hypoxia in the pathogenesis of diabetic -- nephropathy -- Chapter 30. Estimation of kidney oxygenation by BOLD-MRI -- Chapter 31. Anemia and progression of chronic kidney disease -- Section 3. Novel therapeutic approaches against oxidative stress and hypoxia -- Chapter 32. Novel therapeutic approaches against hypoxia and oxidative stress,targeting intracellular sensor molecules for oxygen and oxidative stress -- Chapter 33. Endoplasmic reticulum (ER) stress as a target of therapy against oxidative stress and hypoxia -- Chapter 34. Stem cell therapy against oxidative stress and hypoxia. |
| 520 ## - NOTA DE RESUMEN, ETC. |
|---|
| Summary, etc. |
Conditions such as oxidative stress and hypoxia, which have a generalized impact on the oxygen metabolism, have been implicated in the genesis of kidney disease. This means that deepening our understanding of the pathobiology of oxygen metabolism in such diseases could be a fruitful path towards tangible clinical benefits. Studies in Renal Disorder collects reviews from leading researchers and clinical scientists working in exactly this field, providing an overview of the latest advances. The causal role of impaired oxygen metabolism in kidney disease has numerous clinical implications. It affects our understanding of the therapeutic benefits accruing from anti-hypertensive agents; the way we control hyperglycemia/hyperinsulinemia and hyperlipidemia; and our use of dietary approaches to the correction of obesity. The defensive mechanisms against oxidative stress, such as the Nrf2-Keap1 system, and hypoxia, such as the PHD-HIF system, have recently been explored in various cells, including kidney cells. These mechanisms include intracellular sensors for oxidative stress and hypoxia. This means that novel approaches targeting these sensors may offer clinical benefits in kidney disease in which oxidative stress and/or hypoxia is a final, common pathway. |
| 596 ## - |
|---|
| -- |
19 |
| 650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Life sciences. |
| 650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Nephrology. |
| 650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Cytology. |
| 650 14 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Life Sciences. |
| 650 24 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Oxidative Stress. |
| 650 24 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Cell Biology. |
| 650 24 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
|---|
| Topical term or geographic name as entry element |
Nephrology. |
| 700 1# - ASIENTO SECUNDARIO - NOMBRE PERSONAL |
|---|
| Personal name |
Eckardt, Kai-Uwe. |
| Relator term |
editor. |
| 700 1# - ASIENTO SECUNDARIO - NOMBRE PERSONAL |
|---|
| Personal name |
Nangaku, Masaomi. |
| Relator term |
editor. |
| 710 2# - ASIENTO SECUNDARIO - NOMBRE CORPORATIVO |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Printed edition: |
| International Standard Book Number |
9781607618560 |
| 830 #0 - ASIENTO SECUNDARIO DE SERIE--TITULO UNIFORME |
|---|
| Uniform title |
Oxidative Stress in Applied Basic Research and Clinical Practice |
| 856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS |
|---|
| Public note |
Libro electrónico |
| Uniform Resource Identifier |
<a href="http://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-1-60761-857-7">http://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-1-60761-857-7</a> |
| 942 ## - TIPO DE MATERIAL (KOHA) |
|---|
| Koha item type |
Libro Electrónico |
